In the excitement over yesterday’s 8k from China-Biotics (CHBT) revealing the fake web site scam, read about it here, your author skipped right over CHBT‘s second 8k filing of the afternoon. In it, CHBT discloses more about its delisting notice from NASDAQ.

The delisting is a tardy, albeit expected, and by CHBT standards, tame, development. However, attached to this 8k is a press release, read it here, that is quite fascinating. Scroll all the way down to the bottom and readers will see the re-emergence of blogger-threatening, Chinese reverse merger Investor Relations superstar, Mr. Kevin Theiss.

Contact:

China-Biotics, Inc.

Email: ir@chn-biotics.com

Kevin Theiss

Grayling

Phone: +1-646-284-9409

Email: kevin.theiss@grayling.com

it was quite a surprise to see that he is still employed by Grayling. Read about Kevin‘s other clients, like delinquent China Automotive (CAAS) and shameful China Agritech (CAGC), along with his Very Bad Week, here.

The content contained in this blog represents only the opinions of the author. The author may hold either long or short positions in securities of various companies discussed in the blog. This commentary in no way constitutes investment advice, and should never be relied on in making an investment decision, ever. This blog is not a solicitation of business: all inquiries will be ignored. The content herein is intended solely for the entertainment of the reader, and the author.